Concepedia

Irmela Schrettenbrunner

IS

Statistics

Publications

1

Citations

30

H-Index

1

Active since

2011

Affiliations

Universitätsklinikum Erlangen(Current)

Irmela Schrettenbrunner is an author at Universitätsklinikum Erlangen specializing in cancer therapeutics, oncology, and urology.

Top concepts

Publications per year

2011–2011

1

Publications

1

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial

Bernhard Walter, Irmela Schrettenbrunner, Martin Vogelhuber et al. · Medical Oncology · 2011 · 30 citations

, , +7

1–1 of 1